D Michalovitz1, O Halevy, M Oren
1Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Mutant p53 may actively promote cancer, not just lose tumor suppressor function. Understanding these oncogenic p53 mutations is crucial for developing effective cancer therapies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: